Company research / LEXX
Lexaria Bioscience Corp. (LEXX)
- Sector Manufacturing
- Incorporated NV
- Fiscal year ends Aug 31
For the year ended 2025-08-31, Lexaria Bioscience Corp. reported revenue of $705.9K. Revenue grew 52.0% from the prior annual period.
Key ratios (year ended 2025-08-31)
99.6%
Gross margin
-1683.0%
Operating margin
-1686.0%
Net margin
-398.1%
Return on year-end equity
52.0%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.